DeepMed Research

Organogenesis

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 862

Market Cap: -

Website

Introduction: Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Clinical Trials

A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

Not Applicable

Recruiting

Conditions: Diabetic Foot Ulcer

Interventions: Other: Standard of Care
Device: PuraPly AM
Device: PuraPly XT

First Posted Date: 2024-10-01

Last Posted Date: 2025-04-04

Lead Sponsor: Organogenesis

Target Recruit Count: 170

Registration Number: NCT06618612

Locations: 🇺🇸
Kent State University, College of Podiatric Medicine, Clevland, Ohio, United States

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients with Osteoarthritis of the Knee

Phase 3

Active, not recruiting

Conditions: Knee Osteoarthritis

Interventions: Biological: Amniotic Suspension Allograft
Drug: Placebo

First Posted Date: 2023-08-21

Last Posted Date: 2025-03-21

Lead Sponsor: Organogenesis

Target Recruit Count: 474

Registration Number: NCT06000410

Locations: 🇺🇸
Central Research Associates, Inc., Birmingham, Alabama, United States
🇺🇸
Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
🇺🇸
Fiel Family & Sports Medicine, Tempe, Arizona, United States

and more 37 locations

Clinical Study Of Affinity Versus SOC In The Management Of VLUs

Not Applicable

Conditions: Venous Leg Ulcer

Interventions: Other: Affinity

First Posted Date: 2021-05-25

Last Posted Date: 2021-09-08

Lead Sponsor: Organogenesis

Target Recruit Count: 200

Registration Number: NCT04901013

Locations: 🇺🇸
ILD Research, Carlsbad, California, United States

Efficacy of Amniotic Suspension Allograft in Patients with Osteoarthritis of the Knee

Phase 3

Active, not recruiting

Conditions: Knee Osteoarthritis

Interventions: Drug: Placebo
Biological: Amniotic Suspension Allograft

First Posted Date: 2020-11-19

Last Posted Date: 2025-03-21

Lead Sponsor: Organogenesis

Target Recruit Count: 474

Registration Number: NCT04636229

Locations: 🇺🇸
Klein & Associates, MD, PA, Hagerstown, Maryland, United States
🇺🇸
Stanford Medicine, Redwood City, California, United States
🇺🇸
Gulfcoast Research Institute, Sarasota, Florida, United States

and more 32 locations

Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers

Not Applicable

Conditions: Diabetic Foot Ulcer

Interventions: Other: NuShield

First Posted Date: 2019-02-26

Last Posted Date: 2021-05-26

Lead Sponsor: Organogenesis

Target Recruit Count: 200

Registration Number: NCT03855514

Locations: 🇺🇸
ILD Research Center, Carlsbad, California, United States
🇺🇸
Futuro Clinical Trials, McAllen, Texas, United States
🇺🇸
Extremity Healthcare, Roswell, Georgia, United States

and more 6 locations

PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.

Not Applicable

Terminated

Conditions: Chronic Pressure Ulcers

Interventions: Device: PuraPly® Antimicrobial Wound Matrix
Other: SOC for Pressure Ulcers

First Posted Date: 2018-04-19

Last Posted Date: 2021-09-22

Lead Sponsor: Organogenesis

Target Recruit Count: 40

Registration Number: NCT03502824

Locations: 🇺🇸
Northwell Health, Lake Success, New York, United States
🇺🇸
NYU Winthrop Hospital, Mineola, New York, United States

The RESPOND Registry

Completed

Conditions: Draining Wounds
Partial Thickness Wound
Diabetic Ulcer
Trauma Wounds
Pressure Ulcer
Venous Ulcer
Surgical Wounds
Chronic Vascular Ulcer

First Posted Date: 2017-09-18

Last Posted Date: 2019-02-27

Lead Sponsor: Organogenesis

Target Recruit Count: 310

Registration Number: NCT03286452

Locations: 🇺🇸
Jupiter Medical Center, Jupiter, Florida, United States
🇺🇸
West Gables Rehab Hospital, Miami, Florida, United States
🇺🇸
Saint Louis Foot and Ankle, Saint Louis, Missouri, United States

and more 12 locations

Affinity Prospective Diabetic Foot Trial Crossover Group

Not Applicable

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Other: Affinity human amniotic membrane

First Posted Date: 2017-07-02

Last Posted Date: 2020-02-19

Lead Sponsor: Organogenesis

Target Recruit Count: 20

Registration Number: NCT03205436

Locations: 🇺🇸
GF Professional Research, Miami Lakes, Florida, United States
🇺🇸
Armstrong County Memorial Hospital, Kittanning, Pennsylvania, United States
🇺🇸
SerenaGroup Research Institute, Pittsburgh, Pennsylvania, United States

and more 3 locations

PuraPly™ Antimicrobial Wound Matrix and Wound Management

Completed

Conditions: Diabetic Ulcer
Venous Ulcer
Trauma Wound
Pressure Ulcer
Surgical Wound

First Posted Date: 2017-03-06

Last Posted Date: 2017-11-06

Lead Sponsor: Organogenesis

Target Recruit Count: 100

Registration Number: NCT03070938

Locations: 🇺🇸
Winthrop University Hospital, Mineola, New York, United States

Prospective PuraPly™ AM Case Series Study

Completed

Conditions: Venous Ulcers
Diabetic Ulcers
Trauma Wounds
Surgical Wounds
Pressure Ulcers

First Posted Date: 2017-03-06

Last Posted Date: 2017-08-31

Lead Sponsor: Organogenesis

Target Recruit Count: 43

Registration Number: NCT03070925

Locations: 🇺🇸
Northwell Health, Inc, Lake Success, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy